Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IPSC
#3009
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+6.42%
Mudança mensal
-13.43%
Mudança em 6 meses
+346.15%
Mudança anual
+256.92%
Fechamento anterior
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
Volume
15
Mercados
Ações
Cuidados de saúde
IPSC
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
85.03 M
86.05 M
86.16 M
86.39 M
87.31 M
—
Valuation ratios
Enterprise value
92.81 M
28.46 M
-10.85 M
-8.61 M
-12.04 M
-3.04 M
Price to earnings ratio
-0.93
-0.63
-1.76
-2.07
-1.66
-6.12
Price to sales ratio
43.4
12.06
0.35
0.42
0.38
13.21
Price to cash flow ratio
-1.01
-0.72
-0.33
-0.4
-0.38
-1.82
Price to book ratio
0.15
0.49
0.05
0.06
0.05
0.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.08
0.1
0.24
0.11
0.14
0.6
Return on equity %
0.16
0.22
0.32
0.16
0.2
0.89
Return on invested capital %
67.18
67.16
138.89
98.45
114.82
419.32
Gross margin %
100
100
100
—
—
—
Operating margin %
4 398.1
893.67
67.95
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
3 947.66
864.65
70.13
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.39
1.5
11.7
10.72
6.25
30.16
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0.33
0
0
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.33
0.31
0.4
0.32
0.3
1.33
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.34
2.41
1.92
1.81
1.54
7.67
Net current asset value per share
2.43
2.47
1.97
1.86
1.59
7.89
Tangible book value per share
1.86
1.62
2.4
2.04
1.64
7.69
Working capital per share
2.2
0.82
1.8
1.68
1.34
5.64
Book value per share
2.31
2.05
2.79
2.43
2.04
9.32
Notícias
TD Cowen inicia cobertura de Century Therapeutics com recomendação de compra
TD Cowen initiates Century Therapeutics stock rating at Buy
Clear Street reitera recomendação de compra para ações da Century Therapeutics a US$ 6,60
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Preço-alvo das ações da Century Therapeutics reduzido para US$ 6,60 pela Clear Street
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics secures $135 million in private placement
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors